BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38534395)

  • 1. IF1 Promotes Cellular Proliferation and Inhibits Oxidative Phosphorylation in Mouse Embryonic Fibroblasts under Normoxia and Hypoxia.
    Lauterboeck L; Kang SW; White D; Bao R; Mobasheran P; Yang Q
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP synthase inhibitory factor subunit 1 regulates islet β-cell function via repression of mitochondrial homeostasis.
    Zhang K; Bao R; Huang F; Yang K; Ding Y; Lauterboeck L; Yoshida M; Long Q; Yang Q
    Lab Invest; 2022 Jan; 102(1):69-79. PubMed ID: 34608240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the ATPase inhibitor factor 1 (IF
    Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A
    Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype.
    Domínguez-Zorita S; Romero-Carramiñana I; Santacatterina F; Esparza-Moltó PB; Simó C; Del-Arco A; Núñez de Arenas C; Saiz J; Barbas C; Cuezva JM
    Cell Death Dis; 2023 Jul; 14(7):413. PubMed ID: 37433784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase.
    García-Bermúdez J; Sánchez-Aragó M; Soldevilla B; Del Arco A; Nuevo-Tapioles C; Cuezva JM
    Cell Rep; 2015 Sep; 12(12):2143-55. PubMed ID: 26387949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.
    Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM
    J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
    García-Bermúdez J; Cuezva JM
    Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells.
    Solaini G; Sgarbi G; Baracca A
    Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis.
    Galber C; Fabbian S; Gatto C; Grandi M; Carissimi S; Acosta MJ; Sgarbi G; Tiso N; Argenton F; Solaini G; Baracca A; Bellanda M; Giorgio V
    Cell Death Dis; 2023 Jan; 14(1):54. PubMed ID: 36690622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pro-oncogenic protein IF
    Sgarbi G; Righetti R; Del Dotto V; Grillini S; Giorgio V; Baracca A; Solaini G
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166879. PubMed ID: 37689158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
    Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO
    Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675
    [No Abstract]   [Full Text] [Related]  

  • 12. The Pro-Oncogenic Protein IF
    Righetti R; Grillini S; Del Dotto V; Costanzini A; Liuzzi F; Zanna C; Sgarbi G; Solaini G; Baracca A
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability.
    Fujikawa M; Imamura H; Nakamura J; Yoshida M
    J Biol Chem; 2012 May; 287(22):18781-7. PubMed ID: 22493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism on forcible ejection of ATPase inhibitory factor 1 from mitochondrial ATP synthase.
    Kobayashi R; Ueno H; Okazaki KI; Noji H
    Nat Commun; 2023 Mar; 14(1):1682. PubMed ID: 37002198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor protein IF
    Carroll J; Watt IN; Wright CJ; Ding S; Fearnley IM; Walker JE
    J Biol Chem; 2024 Mar; 300(3):105690. PubMed ID: 38280428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative phosphorylation became functional under aglycemic hypoxia conditions in A549 cells.
    Öğünç Keçeci Y; İncesu Z
    Mol Biol Rep; 2022 Sep; 49(9):8219-8228. PubMed ID: 35834035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F
    Tanton H; Voronina S; Evans A; Armstrong J; Sutton R; Criddle DN; Haynes L; Schmid MC; Campbell F; Costello E; Tepikin AV
    Front Physiol; 2018; 9():833. PubMed ID: 30050450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential.
    Romero-Carramiñana I; Esparza-Moltó PB; Domínguez-Zorita S; Nuevo-Tapioles C; Cuezva JM
    Commun Biol; 2023 Aug; 6(1):836. PubMed ID: 37573449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy.
    Yang K; Long Q; Saja K; Huang F; Pogwizd SM; Zhou L; Yoshida M; Yang Q
    Sci Rep; 2017 Sep; 7(1):10501. PubMed ID: 28874825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.
    Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I
    Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.